Find out more about Mom's Story:
Wednesday, December 22, 2010
Sunday, December 19, 2010
It's not too late to consider giving a gift of love this holiday season: Mom’s Story, A Child Learns About MS, http://www.marynickum.com.
Thursday, December 9, 2010
The United States Food and Drug Administration (FDA) has approved Gilenya (fingolimod) as a first-line treatment for relapsing forms of multiple sclerosis (MS). Gilenya is the first oral disease-modifying therapy available for the long-term treatment of MS. The approval of a treatment that may be taken orally (by mouth), versus injection or infusion, is exciting news for members of the MS community